However, some malignant tumors, including gliomas, acquire mutations in elements of the TGF-β pathway that allow escape from the antiproliferative effects of TGF-β [3, 11], thus facilitating the pro-tumorigenic activity of TGF-β. The gene discussed is TGFB1; the disease is cancer.